Ameriprise’s MaxLinear MXL Stock Holding History

Ameriprise’s Portfolio MXL Stock Details MXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-8,700	Closed	-$275K	–	3938
2023 Q2	$275K	Buy	+8,700	New	+$251K	﹤0.01%	3633

Other funds holding MXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ameriprise's MXL Position: Q1 2026 in Review

Ameriprise reduced its MaxLinear (MXL) stake by 1.6% in Q1 2026, selling an estimated $163K and leaving 557,520 shares worth $9.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1953.

Ameriprise first reported a position in MXL in Q2 2013 and has held it in 50 quarters since. The position peaked at $62M in Q4 2021. 238 funds tracked by Wall St. Rank hold MXL as of Q1 2026.

Ameriprise held 557,520 shares of MaxLinear worth $9.7M as of Q1 2026.
Ameriprise sold 9,053 MaxLinear shares in Q1 2026, an estimated $163K.
MaxLinear made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #1953 holding.
Ameriprise first reported a position in MaxLinear in Q2 2013 and has held it in 50 quarters since.
Ameriprise's MaxLinear position peaked at $62M in Q4 2021.
238 funds tracked by Wall St. Rank held MaxLinear as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.